Available in stereo, ultrasound, and MRI, Mammotome’s proven technology provides clinicians confidence in quality tissue acquisition.
The ability to “take a sample, see a sample” provides open access to the tissue and visual concordance unparalleled by any other breast biopsy device.
The key clinical proof is the nearly 4 million patients
who have undergone the procedure in the last 17 years
and the 280 clinical articles that have been published
on its efficacy.